The physiologic effects of caloric restriction are reflected in the in vivo adipocyte-enriched proteome of overweight/obese subjects

Journal of Proteome Research

Volumn 8, Issue 12, 2009, Pages 5532-5540

  Bouwman, Freek G ^a   Claessens, Mandy ^a   Van Baak, Marleen A ^a   Noben, Jean Paul ^b   Wang, Ping ^a   Saris, Wim H M ^a   Mariman, Edwin C M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Adipose tissue; Caloric restriction; Lipid metabolism; Obesity; Physiologic effects; Proteomics

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACETYL COENZYME A ACETYLTRANSFERASE; ACYL COENZYME A DEHYDROGENASE; ALDO KETOREDUCTASE 1C2; APOLIPOPROTEIN A1; BETA TUBULIN; FATTY ACID BINDING PROTEIN 4; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE C; GLUCOSE; GLUCOSE TRANSPORTER 4; LIPOCORTIN 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDOREDUCTASE; PROTEOME; THIOREDOX INDEPENDENT PEROXIDE REDUCTASE; TUBULIN BETA 5; UNCLASSIFIED DRUG; VIMENTIN;

ADIPOCYTE; ADULT; ARTICLE; BODY FAT; CALORIC RESTRICTION; CLINICAL ARTICLE; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIPID METABOLISM; LOW CALORY DIET; MALE; OBESITY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEOMICS; WEIGHT CHANGE; WEIGHT REDUCTION;

ADIPOCYTES; ADIPOSITY; ADULT; CALORIC RESTRICTION; FEMALE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROTEINS; PROTEOME; PROTEOMICS; WEIGHT LOSS;

EID: 71549126821     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900606m     Document Type: Article

References (42)

1. Bogaert, Y. E.; Linas, S. The role of obesity in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol. 2009, 5 (2), 101-111
2. Wellen, K. E.; Hotamisligil, G. S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112 (12), 1785-1788
3. Berg, A. H.; Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96 (9), 939-949 (Pubitemid 40712793)
4. Mojiminiyi, O. A.; Al Mulla, F.; Abdella, N. A. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus. Med. Princ. Pract. 2009, 18 (2), 123-129
5. Zou, C.; Shao, J. Role of adipocytokines in obesity-associated insulin resistance. J. Nutr. Biochem. 2008, 19 (5), 277-286
6. Goldstein, D. J. Beneficial health effects of modest weight loss. Int. J. Obes. Relat. Metab. Disord. 1992, 16 (6), 397-415.
7. Jazet, I. M.; de Craen, A. J.; van Schie, E. M.; Meinders, A. E. Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabetes Res. Clin. Pract. 2007, 77 (1), 70-76
8. Fontana, L. Calorie restriction and cardiometabolic health. Eur. J. Cardiovasc. Prev. Rehabil. 2008, 15 (1), 3-9.
9. Claessens, M.; Saris, W. H. M.; Bouwman, F. G.; A. Evelo, C. T. A.; Hul, G. B. J.; Blaak, E. E.; Mariman, E. C. M. Differential valine metabolism in adipose tissue of low and high fat-oxidizing obese subjects. Proteomics: Clin. Appl. 2007, 1 (10), 1306-1315.
10. de Roos, B.; Duthie, S. J.; Polley, A. C.; Mulholland, F.; Bouwman, F. G.; Heim, C.; Rucklidge, G. J.; Johnson, I. T.; Mariman, E. C.; Daniel, H.; Elliott, R. M. Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J. Proteome Res. 2008, 7 (6), 2280-2290
11. Claessens, M.; van Baak, M. A.; Monsheimer, S.; Saris, W. H. The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors. Int. J. Obes. 2009, 33 (3), 296-304.
12. Siri, W. E. Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition 1993, 9 (5), 480-91, discussion 480, 492.
13. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254
14. Rabilloud, T.; Adessi, C.; Giraudel, A.; Lunardi, J. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1997, 18 (3-4), 307-316 (Pubitemid 27174413)
15. Gorg, A.; Obermaier, C.; Boguth, G.; Harder, A.; Scheibe, B.; Wildgruber, R.; Weiss, W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21 (6), 1037-1053 (Pubitemid 30230771)
16. Bouwman, F.; Renes, J.; Mariman, E. A combination of protein profiling and isotopomer analysis using matrix-assisted laser desorption/ionization-time of flight mass spectrometry reveals an active metabolism of the extracellular matrix of 3T3-L1 adipocytes. Proteomics 2004, 4 (12), 3855-3863 (Pubitemid 39657462)
17. Bouwman, F.; Suylen, D.; Renes, J.; Mariman, E. Evaluation and improving the success rate of protein identification by peptide mass fingerprinting using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19 (17), 2465-2468 (Pubitemid 41284997)
18. Dumont, D.; Noben, J. P.; Raus, J.; Stinissen, P.; Robben, J. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4 (7), 2117-2124 (Pubitemid 38880377)
19. Koopman, R.; Zorenc, A. H.; Gransier, R. J.; Cameron-Smith, D.; van Loon, L. J. Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers. Am. J. Physiol.: Endocrinol. Metab. 2006, 290 (6), E1245-52.
20. Strimmer, K. A unified approach to false discovery rate estimation. BMC Bioinf. 2008, 9, 303. (Pubitemid 352025239)
21. Kao, A. W.; Noda, Y.; Johnson, J. H.; Pessin, J. E.; Saltiel, A. R. Aldolase mediates the association of F-actin with the insulin-responsive glucose transporter GLUT4. J. Biol. Chem. 1999, 274 (25), 17742-17747 (Pubitemid 129519130)
22. Volker, K. W.; Knull, H. A glycolytic enzyme binding domain on tubulin. Arch. Biochem. Biophys. 1997, 338 (2), 237-243 (Pubitemid 27200519)
23. Huang, J.; Hsia, S. H.; Imamura, T.; Usui, I.; Olefsky, J. M. Annexin II is a thiazolidinedione-responsive gene involved in insulin-induced glucose transporter isoform 4 translocation in 3T3-L1 adipocytes. Endocrinology 2004, 145 (4), 1579-1586
24. Wang, P.; Bouwman, F. G.; Mariman, E. C. Generally detected proteins in comparative proteomics - a matter of cellular stress response. Proteomics 2009, 9 (11), 2955-2966
25. Fong, B. S.; Rodrigues, P. O.; Salter, A. M.; Yip, B. P.; Despres, J. P.; Angel, A.; Gregg, R. E. Characterization of high density lipoprotein binding to human adipocyte plasma membranes. J. Clin. Invest. 1985, 75 (6), 1804-1812 (Pubitemid 15237788)
26. Despres, J. P.; Fong, B. S.; Julien, P.; Jimenez, J.; Angel, A. Regional variation in HDL metabolism in human fat cells: effect of cell size. Am. J. Physiol. 1987, 252 (5 Pt 1), E654-9.
27. Van Lenten, B. J.; Wagner, A. C.; Jung, C. L.; Ruchala, P.; Waring, A. J.; Lehrer, R. I.; Watson, A. D.; Hama, S.; Navab, M.; Anantharamaiah, G. M.; Fogelman, A. M. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 2008, 49 (11), 2302-2311
28. Navab, M.; Anantharamaiah, G. M.; Fogelman, A. M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 2005, 15 (4), 158-161
29. Tabet, F.; Rye, K. A. High-density lipoproteins, inflammation and oxidative stress. Clin. Sci. 2009, 116 (2), 87-98.
30. Hoeg, J. M.; Meng, M. S.; Ronan, R.; Fairwell, T.; Brewer, H. B., Jr.; Human apolipoprotein, A.-I. Post-translational modification by fatty acid acylation. J. Biol. Chem. 1986, 261 (9), 3911-3914
31. Nadolski, M. J.; Linder, M. E. Protein lipidation. FEBS J. 2007, 274 (20), 5202-5210
32. Brewer, H. B., Jr.; Fairwell, T.; Kay, L.; Meng, M.; Ronan, R.; Law, S.; Light, J. A. Human plasma proapoA-I: isolation and aminoterminal sequence. Biochem. Biophys. Res. Commun. 1983, 113 (2), 626-632
33. Pyle, L. E.; Sviridov, D.; Fidge, N. H. Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro model. Biochemistry 2001, 40 (10), 3101-3108
34. Masaki, M.; Ikeda, A.; Shiraki, E.; Oka, S.; Kawasaki, T. Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB synergistically. Eur. J. Biochem. 2003, 270 (1), 76-83. (Pubitemid 36056939)
35. Funatsumaru, S. Cellular structure and function of rat fat cells in the primary culture. Cell Struct. Funct. 1995, 20 (1), 23-32.
36. Lieber, J. G.; Evans, R. M. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J. Cell Sci. 1996, 109 (Pt. 13), 3047-3058
37. Jackman, M. R.; Steig, A.; Higgins, J. A.; Johnson, G. C.; Fleming-Elder, B. K.; Bessesen, D. H.; MacLean, P. S. Weight regain after sustained weight reduction is accompanied by suppressed oxidation of dietary fat and adipocyte hyperplasia. Am. J. Physiol.: Regul. Integr. Comp. Physiol. 2008, 294 (4), R1117-29.
38. van Aggel-Leijssen, D. P.; Saris, W. H.; Hul, G. B.; van Baak, M. A. Short-term effects of weight loss with or without low-intensity exercise training on fat metabolism in obese men. Am. J. Clin. Nutr. 2001, 73 (3), 523-531
39. Nicklas, B. J.; Rogus, E. M.; Goldberg, A. P. Exercise blunts declines in lipolysis and fat oxidation after dietary-induced weight loss in obese older women. Am. J. Physiol. 1997, 273 (1 Pt. 1), E149-55.
40. Blouin, K.; Blanchette, S.; Richard, C.; Dupont, P.; Luu-The, V.; Tchernof, A. Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. Am. J. Physiol.: Endocrinol. Metab. 2005, 288 (2), E398-404.
41. Pohl, J.; Ring, A.; Ehehalt, R.; Schulze-Bergkamen, H.; Schad, A.; Verkade, P.; Stremmel, W. Long-chain fatty acid uptake into adipocytes depends on lipid raft function. Biochemistry 2004, 43 (14), 4179-4187 (Pubitemid 38445638)
42. Chui, P. C.; Guan, H. P.; Lehrke, M.; Lazar, M. A. PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J. Clin. Invest. 2005, 115 (8), 2244-2256